With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...
Conventional catalyst designs have largely focused on thermodynamic properties, such as adsorption energy, to optimize ...
Researchers have uncovered a new principle that could accelerate the development of cheaper and more efficient fuel cells by ...
When you hear the word "epoxide," what do you think? If anything, likely "glue." But epoxides are quite common in our ...
A new copper-magnesium-iron catalyst transforms CO2 into CO at low temperatures with record-breaking efficiency and stability. The discovery paves the way for affordable, scalable production of carbon ...
State-backed CDP Equity to have a stake in combined entity Deal comes after Chiesi's $1.9 billion buyout of U.S. KalVista Angelini aims to create global player in rare disease drugs ROME/MILAN, May 7 ...
As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their businesses running. She uses the experience of managing her own writing and editing ...
ChatGPT forecasts XRP will reach $2.15 by December, giving the prediction a 50% probability, which is a 40% gain from today’s price. The AI says XRP needs to hold above $1.50 in the next few weeks for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results